|
|
4-Antibody is a biopharmaceutical company with a powerful fully-human antibody drug-discovery technology platform.
|
|
|
|
La société a pour but la recherche, l'étude, le développement, la fabrication, la promotion et la commercialisation de produits et de substances dans le domaine pharmaceutique et nutritionnel.
|
|
|
|
The mission of AC Immune is to identify and develop “best in class” innovative therapies for Alzheimer´s Disease and other conformational diseases.
|
|
|
|
Focused on the development of proprietary Antibody Drug Conjugates for the treatment of cancer.
|
|
|
|
he company focuses its drug discovery programs on therapeutically validated targets and directs its translational clinical research to indications of high medical need.
|
|
|
|
Development and progression of a new generation of cancer vaccines
|
|
|
|
Single Cell Analysis.
|
|
|
|
Anergis develops Breakthrough Allergy Vaccines.
|
|
|
|
Revolutionary vaccines for unmet medical needs
|
|
|
|
effective modes of delivery for small molecules and peptides.
|
|
|
|
Insecticides and fungicides of biological origin.
|
|
|
|
Innovative diagnostic and drug discovery tools.
|
|
|
|
Efficient and safe subunit drugs.
|
|
|
|
Providing Unique Biological Solutions for Treating Waste
|
|
|
|
Market leader for biodegradable retail bags.
|
|
|
|
BioEqual owns patents on substances, able to penetrate skin and nails.
|
|
|
|
New standard in multiplexed protein quantification.
|
|
|
|
Molecular diagnostic tests for personalized medicine.
|
|
|
|
Bacterial transcriptional regulators, which initiate bacterial defense mechanisms causing drug resistance.
|
|
|
|
BioXpress Therapeutics SA is a premier provider of high-quality biosimilar biologic APIs for unmet need indications.
|
|
|
|
Make better choices for dating and relationships.
|
|
|
|
C-CIT AG is the innovative sensor specialist for biotechnology, research, environment and frying oil.
|
|
|
|
Programs in inflammatory bowel diseases.
|
|
|
|
Therapies for cardiovascular diseases.
|
|
|
|
Entwicklung, die Herstellung, den Handel und den Vertrieb von analytischen Instrumenten und Geräten.
|
|
|
|
Innovative culture media, 2D and 3D in vitro models.
|
|
|
|
ChromaCon AG is a biopharmaceutical company providing enabling purification technologies, equipment and services.
|
|
|
|
Pharmazeutischen und diagnostische Produkte.
|
|
|
|
Clariness speeds up clinical trials for its customers in the pharmaceutical industry in order to reduce time to market of newly developed drugs.
|
|
|
|
COMBAGROUP implements a new way of growing lettuce.
|
|
|
|
Covagen exploits the unique versatility of Fynomers to create next generation biologics.
|
|
|
|
CovalX Services is providing a direct access to the technology and know-how of the leader in the field of interaction analysis by High-Mass MALDI mass spectrometry.
|
|
|
|
Novel, human-derived antibodies for the treatment of cancer.
|
|
|
|
Culture Collection of Switzerland.
|
|
|
|
A platform technology for efficient culture of cells on extendable surfaces.
|
|
|
|
Development of highly sensitive easy to use low background fast and competitive diagnostic kits for research and health care applications.
|
|
|
|
Developing therapeutic antibodies against serious medical conditions with high unmet need.
|
|
|
|
Simplifying colon screening.
|
|
|
|
drugdesigntech develops innovative computational solutions to support drug discovery.
|
|
|
|
Dybly develops pharmaceutical products for patients affected by the build-up of atherosclerotic plaques.
|
|
|
|
Dynamic Drug Design deals with the transfer of novel software technology for drug design
|
|
|
|
Significant and durable improvement in the health and quality of life to future generations affected by the rare genetic disorder, X-linked Hypohidrotic Ectodermal Dysplasia (XLHED).
|
|
|
|
Entwicklung von Arzneimitteln zur Behandlung von Psoriasis(Schuppenflechte).
|
|
|
|
Innovative In Vitro Solutions for Respiratory Diseases and Chemical Testing.
|
|
|
|
Innovative expression systems design.
|
|
|
|
Improving Lives with Synthetic Biology.
|
|
|
|
Novel surfaces for enhanced cell culture.
|
|
|
|
The company provides services for private or academic research laboratories.
|
|
|
|
Enzyme-based drugs and agents.
|
|
|
|
Discovery, development and commercialization of innovative treatments.
|
|
|
|
GeNeuro develops a pioneering approach for the therapy and diagnosis of diseases associated with human endogenous retrovirus expression.
|
|
|
|
GenKyoTex. An Innovative Approach for the Treatment of Pathologies Associated with Overproduction of Oxygen Radicals.
|
|
|
|
Development of a naturally occurring bile acid as functional food
|
|
|
|
Development of novel biotechnological methods for the production of glycoconjugates.
|
|
|
|
Captors and measure instruments for biology and pharmaceuticals.
|
|
|
|
Développement,In-licensing, production sous-contract et distribution de produits Pharmaceutiques et Biotechnologiques
|
|
|
|
Developing and producing natural substances for human and animal health.
|
|
|
|
Développement et commercialisation de médicaments
|
|
|
|
iNNutriGEL owns the exclusive and worldwide rights for all food applications of a series of InnoGEL patents around the starch network technology.
|
|
|
|
3D microtissues for drug discovery and cell therapy.
|
|
|
|
Relying on breakthrough research in chemical biology Intrace Medical develops markers that reliably identify tissue affected by cancer or bacterial infection in vivo.
|
|
|
|
Development novel, fully human monoclonal antibodies.
|
|
|
|
KNLN-Innovation développe "Zilooa" des cosmétiques novateurs ménageant l’environnement naturel.
|
|
|
|
LASCCO SA is a biomedical-technology development private company based in Geneva.
|
|
|
|
Chirurgie du cartilage articulaire
|
|
|
|
A breakthrough in Oncology Supportive Care and Dermatology.
|
|
|
|
Forschung, Entwicklung und Vermarktung von immun-suppressiven Therapien und Diagnosen.
|
|
|
|
For the first time, microscopes combine nanometric resolution, real-time and non-invasive three dimensional observation.
|
|
|
|
Mabimmune aims to prevent myocardial infarction and stroke through early diagnosis and targeted treatment.
|
|
|
|
Platform to identify carbohydrate targets in pathogenic organisms.
|
|
|
|
Highly specific treatments for uro-genital cancers.
|
|
|
|
Medipol develops next generation immunotherapeutic treatments.
|
|
|
|
Novel therapeutics against cancer.
|
|
|
|
Microbiological testing.
|
|
|
|
Miniaturized laboratory equipment for biological applications.
|
|
|
|
Development of a peptidic neurotrophic factor (NRG-101).
|
|
|
|
Targeted Protein Therapeutics Beyond Antibodies.
|
|
|
|
Innovative pill based technology for diagnosis of the digestive system.
|
|
|
|
Navigation systems for surgeons
|
|
|
|
Antibody-based NBEs.
|
|
|
|
Neurimmune is an emerging biotechnology company dedicated to the identification of novel therapeutics for the treatment of human diseases with a focus on neurodegenerative disorders such as Alzheimer’s disease.
|
|
|
|
Neurotune develops medications for neuropathic pain and sarcopenia.
|
|
|
|
Noorik intends to develop N-001 for the prevention of Contrast-Induced Acute Kidney Injury.
|
|
|
|
Conseil et support efficience organisationnelle et Business development international
|
|
|
|
Innovates and develops antibody-based therapeutics.
|
|
|
|
As “the weight switch company” Obexia is focused on important targets in central pathways regulating energy balance.
|
|
|
|
Defining the clinical potential of promising oncology drug candidates.
|
|
|
|
Development and implementation of? new medications for Rare Diseases.
|
|
|
|
Développement et promotion d'extraits de plantes alpines et de probiotiques dans le domaine de la santé de la femme
|
|
|
|
Innovative anti-cancer and stem cell therapies.
|
|
|
|
PhotoDerma SA is a development stage company engaged in research and development of novel cosmetics and pharmaceutics.
|
|
|
|
First-in-class drug candidates against life-threatening viral infections.
|
|
|
|
The creation of a pharmaceutical spin-off company that develops and commercializes personalized cancer medicines
|
|
|
|
LECS has become the tool of choice for high-speed simulations of power electronic systems.
|
|
|
|
Your partner in drug validation: in vivo preclinical testing platform.
|
|
|
|
Develop innovative drugs to improve the quality of life of people who suffer from Parkinson’s disease and other brain disorders.
|
|
|
|
Safer Faster Injectors.
|
|
|
|
Development of markers for the early detection and monitoring of prostate cancer.
|
|
|
|
A novel hydrogel material.
|
|
|
|
Qwane Biosciences is commercializing and further developing Micro-Electrode Array (MEA) biochips for basic research in electrophysiology, secondary drug screening and safety pharmacology applications.
|
|
|
|
Development of new vaccines, including active agents for three different disease areas.
|
|
|
|
Innovative and flexible technology to produce high-quality plant-derived compounds reliably and at low cost.
|
|
|
|
Ultra-rapid detection of pathogenic microorganisms in water and food.
|
|
|
|
Development of topical Methima-zole
|
|
|
|
SDK BioTechnologies develops and promotes high-value enabling scientific instrumentation, products and solutions for analyte-detection-related applications in order to facilitate and accelerate laboratory output.
|
|
|
|
Selexis offers technologies for the rapid development of High Performance of Mammalian Cell Lines useful for discovery/pre-clinical, clinical and commercial production purposes.
|
|
|
|
Biomedical monitoring tools in the fields of sport and healthcare.
|
|
|
|
Sensile Medical is a Swiss company that serves as an incubator for innovative and technology driven medical devices.
|
|
|
|
A breakthrough solution to continuously monitor fluctuations of intraocular pressure in glaucoma treatment.
|
|
|
|
Secure storage and analysis of patient genome sequence information.
|
|
|
|
Marketplace for carbon credits.
|
|
|
|
Developing fully automated and miniaturized systems enabling extraction, manipulation and detection of biochemical substances.
|
|
|
|
Stemergie Biotechnology SA targets the roots of cancer in developing treatments and diagnostics against brain tumor cancer stem cells (CSCs)
|
|
|
|
The mission of TCMetrix is to provide researchers in clinical and basic sciences worldwide with innovative, state-of-the-art T cell monitoring reagents of high quality, to meet the increasing needs for conclusive and comprehensive MHC class I and class II T cell monitoring and analysis.
|
|
|
|
Targeted immunity in the treatment of cancer and other diseases.
|
|
|
|
TransCure Biosciences (TCB) is providing humanized mice for pharmaceutical companies
|
|
|
|
Overcoming Pathogenic Resistance.
|
|
|
|
Vaxeal développe une nouvelle génération de vaccins thérapeutiques
|
|
|
|
Developing Active Anti-angiogenic Immunotherapies for Cancer Patients.
|
|
|
|
Developing and commercializing a new generation of anti-viral products
|
|
|
|
Virometix develops a new generation of vaccines using its Synthetic Virus-Like Particle (SVLP) technology, which enables the creation of a novel type of synthetic nanoparticles.
|
|
|
|
Developing Monolocal Antibodies Agains Metastasis.
|
|